CC
CPXX

Caxton Corporation’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Caxton Corporation’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,232,272
Closed -$67.4M – 15
2016
Q2 		$67.4M Sell
2,232,272
-90,497
-4% -$1.84M 76% 1
2016
Q1 		$25.6M Buy
2,322,769
+76,300
+3% +$250K 35.36% 2
2015
Q4 		$3.95M Hold
2,246,469
– – 16.59% 3
2015
Q3 		$3.73M Hold
2,246,469
– – 5.03% 2
2015
Q2 		$5.03M Hold
2,246,469
– – 5.33% 2
2015
Q1 		$5.55M Hold
2,246,469
– – 6.62% 2
2014
Q4 		$4.4M Hold
2,246,469
– – 5.07% 2
2014
Q3 		$5.68M Hold
2,246,469
– – 5.85% 2
2014
Q2 		$6.65M Hold
2,246,469
– – 5.13% 2
2014
Q1 		$7.12M Hold
2,246,469
– – 5.44% 2
2013
Q4 		$7.3M Buy
+2,246,469
New +$7.7M 4.64% 2

Caxton Corporation's CPXX Position: Q3 2016 in Review

Caxton Corporation sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 2,232,272 shares — an estimated $67.4M sold.

Caxton Corporation first reported a position in CPXX in Q4 2013 and held it in 11 quarters. The position peaked at $67.4M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Caxton Corporation reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Caxton Corporation sold 2,232,272 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $67.4M.
  • Caxton Corporation first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2013 and held it in 11 quarters.
  • Caxton Corporation's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $67.4M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Caxton Corporation's 13F filing for Q3 2016, filed 14 Nov 2016.